RW Malone MD LLC is proud to have played a key role in enabling the enormous success of developing an effective Ebola vaccine within 12 months. August 2014, colleagues at the Department of Defense/Defense Threat Reduction Agency asked us to step in and help NewLink manage the project and develop the contracts necessary to move the "orphan" PHAC/rVSV ZEBOV vaccine forward quickly. We got the project on track, recruited our client Focus Clinical Trials to team with USAMRIID/WRAIR to develop the immunoassays, put WHO leadership in touch with Pentagon leadership to expedite the initial WRAIR clinical trials, recruited the government of Norway to help fund the clinical research, used social media (LinkedIn) to recruit Merck Vaccines to join the project, recruited a management team, and lead the development of the BARDA and DTRA contracts - yielding over 200M$ in resources. Those were frightening times, but now we have a remarkably effective vaccine, developed in record time. The US Army Medical Corps, Medical Countermeasure Systems (MCS) and the DoD Defense Threat Reduction Agency (DTRA) took risks and got the job done, on time and on budget, with little fanfare, and we were grateful to have been able to serve and assist with this huge accomplishment.